Literature DB >> 25612521

"Core out" or "curettage" in rectal advancement flap for cryptoglandular anal fistula.

Natalia Uribe1, Zutoia Balciscueta, Miguel Mínguez, Ma Carmen Martín, Manuel López, Francisco Mora, Vicent Primo.   

Abstract

AIM: Transanal advancement flap is a recognized technique for complex fistula. Management of the tract is open to discussion. Excision of the tract by the "core out" technique is difficult and could increase the risk of sphincter damage. Curettage is easier but it could increase the risk of recurrence. The aim of the present study was to assess the effect of both techniques on sphincter function and to study the clinical results.
METHOD: This is a retrospective analysis from a prospective database. One hundred nineteen consecutive patients with high cryptoglandular anal fistula were included. "Core out" technique was performed in 78 patients (group I) and "curettage" in 41 (group II). In both, a full-thickness rectal flap was advanced over the closed internal defect. Anorectal manometry was performed to assess sphincter function. Continence was assessed using the Wexner Scale. Recurrence was defined as the presence of an abscess or fistulization.
RESULTS: Manometric results showed a significant decrease in the maximum resting pressure after surgery in both groups. The maximum squeeze pressure was significantly reduced only in group I (p < 0.001). No significant changes in Wexner score were observed. The overall recurrence rate was 5.88%, five of group I (6.4%) and two of group II (4.9%), without statistical significance (p = 0.74).
CONCLUSIONS: The core-out technique causes a significant decrease in squeeze pressures, which reflects damage to the external anal sphincter. This could lead to incontinence in high-risk patients. Curettage is a simple technique that preserves the values of squeeze pressures without increasing recurrence rates.

Entities:  

Mesh:

Year:  2015        PMID: 25612521     DOI: 10.1007/s00384-015-2133-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  26 in total

1.  Functional results after transanal rectal advancement flap repair of trans-sphincteric fistula.

Authors:  M E Kreis; E C Jehle; M Ohlemann; H D Becker; M J Starlinger
Journal:  Br J Surg       Date:  1998-02       Impact factor: 6.939

2.  Flap advancement and core fistulectomy for complex rectal fistula.

Authors:  G V Miller; P J Finan
Journal:  Br J Surg       Date:  1998-01       Impact factor: 6.939

3.  Fibrin glue as an adjunct to flap repair of anal fistulas: a randomized, controlled study.

Authors:  C Neal Ellis; Stephen Clark
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

4.  Long-term analysis of the use of transanal rectal advancement flaps for complicated anorectal/vaginal fistulas.

Authors:  G Ozuner; T L Hull; J Cartmill; V W Fazio
Journal:  Dis Colon Rectum       Date:  1996-01       Impact factor: 4.585

5.  Clinical results and manometric studies after rectal flap advancement for infra-levator trans-sphincteric fistula-in-ano.

Authors:  W G Lewis; P J Finan; P J Holdsworth; P M Sagar; B M Stephenson
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

6.  Randomized clinical trial of local gentamicin-collagen treatment in advancement flap repair for anal fistula.

Authors:  U-M Gustafsson; W Graf
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

7.  Mucosal advancement in the treatment of anal fistula.

Authors:  P S Aguilar; G Plasencia; T G Hardy; R F Hartmann; W R Stewart
Journal:  Dis Colon Rectum       Date:  1985-07       Impact factor: 4.585

8.  Fistulectomy and sphincteric reconstruction for complex cryptoglandular fistulas.

Authors:  J V Roig; J García-Armengol; J C Jordán; D Moro; E García-Granero; R Alós
Journal:  Colorectal Dis       Date:  2009-07-09       Impact factor: 3.788

9.  Management of high recurrent anal fistula.

Authors:  C Oh
Journal:  Surgery       Date:  1983-02       Impact factor: 3.982

10.  Endorectal advancement flaps in the treatment of high anal fistula of cryptoglandular origin: full-thickness vs. mucosal-rectum flaps.

Authors:  Peter C Dubsky; Anton Stift; Josef Friedl; Bela Teleky; Friedrich Herbst
Journal:  Dis Colon Rectum       Date:  2008-03-04       Impact factor: 4.585

View more
  6 in total

Review 1.  Rectal advancement flap for the treatment of complex cryptoglandular anal fistulas: a systematic review and meta-analysis.

Authors:  Zutoia Balciscueta; Natalia Uribe; Izaskun Balciscueta; Juan Carlos Andreu-Ballester; Eduardo García-Granero
Journal:  Int J Colorectal Dis       Date:  2017-02-28       Impact factor: 2.571

2.  Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas.

Authors:  M E Stellingwerf; E M van Praag; P J Tozer; W A Bemelman; C J Buskens
Journal:  BJS Open       Date:  2019-01-21

3.  Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a prospective case-control study.

Authors:  Yang Zhang; Min Ni; Chungen Zhou; Yehuang Wang; Yaxian Wang; Yang Shi; Jing Jin; Rui Zhang; Bin Jiang
Journal:  Stem Cell Res Ther       Date:  2020-11-10       Impact factor: 6.832

4.  Efficacy and Safety of Sphincter-Preserving Surgery in the Treatment of Complex Anal Fistula: A Network Meta-Analysis.

Authors:  Hua Huang; Lijiang Ji; Yunfei Gu; Youran Li; Shanshan Xu
Journal:  Front Surg       Date:  2022-02-08

5.  3D high-resolution anorectal manometry in patients with perianal fistulas: comparison with 3D-anal ultrasound.

Authors:  Richelle J F Felt-Bersma; Maarten S Vlietstra; Paul F Vollebregt; Ingrid J M Han-Geurts; Vera Rempe-Sorm; Grietje J H Vander Mijnsbrugge; Charlotte B H Molenaar
Journal:  BMC Gastroenterol       Date:  2018-04-04       Impact factor: 3.067

6.  Autologous adipose-derived stem cells for the treatment of Crohn's fistula-in-ano: an open-label, controlled trial.

Authors:  Chungen Zhou; Meng Li; Yang Zhang; Min Ni; Yehuang Wang; Dachao Xu; Yang Shi; Bo Zhang; Yanni Chen; Yan Huang; Sumin Zhang; Hongzhen Shi; Bin Jiang
Journal:  Stem Cell Res Ther       Date:  2020-03-17       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.